Literature DB >> 8124058

Hyperhomocysteinemia and the response to vitamin supplementation.

J B Ubbink1, A van der Merwe, W J Vermaak, R Delport.   

Abstract

The long-term vitamin requirements of men (n = 22) with moderate hyperhomocysteinemia (plasma total homocysteine concentration > 16.3 mumol/l) were investigated over a period of 48 weeks. An initial 6-week period of vitamin supplementation (1.0 mg folic acid, 10 mg pyridoxine, 0.05 mg cyanocobalamin) reduced plasma homocysteine levels 54.7% (P < 0.001). However, 18 weeks after vitamin therapy was discontinued, only seven participants (subgroup A) still had plasma homocysteine levels of 16.3 mumol/l or lower. The remainder of the participants (subgroup B) required a second 6-week period of vitamin therapy to normalize the elevated plasma homocysteine levels. Substitution of vitamin supplementation by dietary guidelines to increase folate intake from food products failed to maintain normal plasma homocysteine levels in participants from subgroup B. Long-term vitamin supplementation may be required in some individuals to prevent hyperhomocysteinemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8124058     DOI: 10.1007/bf00180030

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  24 in total

Review 1.  Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment.

Authors:  L Brattström; B Israelsson; B Norrving; D Bergqvist; J Thörne; B Hultberg; A Hamfelt
Journal:  Atherosclerosis       Date:  1990-02       Impact factor: 5.162

2.  Plasma homocyst(e)ine levels in men with premature coronary artery disease.

Authors:  J J Genest; J R McNamara; D N Salem; P W Wilson; E J Schaefer; M R Malinow
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

3.  Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease.

Authors:  L E Brattstrom; J E Hardebo; B L Hultberg
Journal:  Stroke       Date:  1984 Nov-Dec       Impact factor: 7.914

Review 4.  Metabolism of sulfur-containing amino acids.

Authors:  M H Stipanuk
Journal:  Annu Rev Nutr       Date:  1986       Impact factor: 11.848

5.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.

Authors:  G Starkebaum; J M Harlan
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

6.  Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor.

Authors:  S Parthasarathy
Journal:  Biochim Biophys Acta       Date:  1987-02-14

7.  The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.

Authors:  L M Taylor; R D DeFrang; E J Harris; J M Porter
Journal:  J Vasc Surg       Date:  1991-01       Impact factor: 4.268

8.  Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.

Authors:  P C Harpel; V T Chang; W Borth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.

Authors:  B M Coull; M R Malinow; N Beamer; G Sexton; F Nordt; P de Garmo
Journal:  Stroke       Date:  1990-04       Impact factor: 7.914

10.  Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism.

Authors:  A M Svardal; R Djurhuus; H Refsum; P M Ueland
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

View more
  11 in total

1.  [A young patient with multiple arterial occlusions].

Authors:  C Panzere; A Brieke; B Bräuer; F Eggemann; H M Becker; P Dieterle
Journal:  Med Klin (Munich)       Date:  1998-05-15

2.  Hyperhomocysteinemia--a risk factor for abruptio placentae.

Authors:  E P Owen; L Human; A A Carolissen; E H Harley; H J Odendaal
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

3.  Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1998-03-21

Review 4.  The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia.

Authors:  J B Ubbink
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 5.  Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature.

Authors:  B V Taylor; G Y Oudit; M Evans
Journal:  Can Fam Physician       Date:  2000-11       Impact factor: 3.275

6.  Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.

Authors:  G L Booth; E E Wang
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

7.  Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion.

Authors:  S Boyd; D Owens; T Gin; K Bunce; H Sherafat; D Perry; P G Hykin
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

8.  A folate-rich diet is as effective as folic acid from supplements in decreasing plasma homocysteine concentrations.

Authors:  Xavier Pintó; M Antonia Vilaseca; Susana Balcells; Rafael Artuch; Emili Corbella; José F Meco; Ramon Vila; Ramon Pujol; Daniel Grinberg
Journal:  Int J Med Sci       Date:  2005-04-01       Impact factor: 3.738

9.  Elevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjects.

Authors:  Mohamed El-Sammak; Mona Kandil; Safaa El-Hifni; Randa Hosni; Mahmoud Ragab
Journal:  Int J Med Sci       Date:  2004-10-12       Impact factor: 3.738

10.  Lowering homocysteine and modifying nutritional status with folic acid and vitamin B(12) in Indian patients of vascular disease.

Authors:  Seema Bhargava; Arif Ali; Eishaan Kamta Bhargava; Anjali Manocha; Mamta Kankra; Sabari Das; Lalit Mohan Srivastava
Journal:  J Clin Biochem Nutr       Date:  2012-02-10       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.